Reversible Posterior Leukoencephalopathy Syndrome after Eribulin Mesylate Chemotherapy for Breast Cancer
- PMID: 28139871
- DOI: 10.1111/tbj.12776
Reversible Posterior Leukoencephalopathy Syndrome after Eribulin Mesylate Chemotherapy for Breast Cancer
Comment on
-
A reversible posterior leukoencephalopathy syndrome.N Engl J Med. 1996 Feb 22;334(8):494-500. doi: 10.1056/NEJM199602223340803. N Engl J Med. 1996. PMID: 8559202
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical